ITIHs, LYVE-1, RHAMM, HAPLN1, and PHBP levels are elevated in certain tumour types, while decreased expression of these HAIMs has been evident in other malignancies [41,56,92,105,110,111,115,116,125,126]. This evidence concerns the gene LYVE1 and neoplasm.